Advertisement
Journal Home
Search for

Articles in Press

Return to articles in press list

Vitamin E decreases endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells

Jean-François LandrierabcCorresponding Author Informationemail address, Erwan Gourantonabc, Emmanuelle Reboulabc, Nicolas Cardinaultabc, Claire El Yazidiabc, Christiane Malezet-Desmoulinsabc, Marc Andréabc, Marion Nowickiabc, Maâmar Souidid, Patrick Borelabc

Received 27 July 2009; received in revised form 17 October 2009; accepted 20 October 2009. published online 10 February 2010.
Corrected Proof

Abstract 

Intestine is the gateway for newly absorbed tocopherols. This organ also plays a crucial role in cholesterol metabolism. Because tocopherols are known to impact cholesterol metabolism in the liver, we hypothesized that tocopherols could also modulate cholesterol metabolism in the intestine. This study aimed to verify this hypothesis and to unveil the mechanisms involved, using Caco-2 cells as a model of the human intestinal cell.

Both α- and γ-tocopherol significantly (P<.05) decreased endogenous cholesterol synthesis and apo-AI-mediated cholesterol secretion in Caco-2 cells. Tocopherols down-regulated (P<.05) up to half of the genes involved in the cholesterol synthesis pathway, together with CYP27A1, which is involved in oxysterol production. The activity of this enzyme, as well as the levels of intracellular oxysterols, was significantly diminished by tocopherols. Finally, tocopherols significantly reduced ABCA1 mRNA levels in Caco-2 cells.

We conclude that tocopherols impair the endogenous synthesis and apo-AI-mediated secretion of cholesterol in Caco-2 cells. This effect involves a down-regulation of genes involved in the cholesterol synthesis pathway, resulting in down-regulation of CYP27A1 which, in turn, diminishes oxysterol concentrations. The outcome is a decrease of LXR activity, resulting in down-regulation of ABCA1. These data reinforce the effect of α- and γ-tocopherol on cholesterol metabolism via gene expression regulation.

a INRA, UMR1260 «Nutriments Lipidiques et Prévention des Maladies Métaboliques», Marseille, F-13385 France

b INSERM, U476, Marseille, F-13385 France

c Faculté de Médecine, Univ Aix-Marseille 1, Univ Aix-Marseille 2, IPHM-IFR 125, Marseille, F-13385 France

d Radiological Protection and Human Health Division, Radiobiology and Epidemiology Department, Laboratory of Experimental Toxicology, Institute for Radiological Protection and Nuclear Safety (IRSN), BP n°17, F-92262 Fontenay-aux-Roses CEDEX, France

Corresponding Author InformationCorresponding author. Faculté de Médecine, UMR 1260 INRA/476 INSERM, 27 boulevard Jean-Moulin, 13385 Marseille Cedex 5, France. Tel.: +33 4 91 29 41 02; fax: +33 4 91 78 21 01.

 This work was funded by INRA and INSERM.

PII: S0955-2863(09)00222-8

doi:10.1016/j.jnutbio.2009.10.008

Advertisement